These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1150 related items for PubMed ID: 28123944
1. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y. Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944 [Abstract] [Full Text] [Related]
2. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. Geng C, Xu H, Zhang Y, Gao Y, Li M, Liu X, Gao M, Wang X, Liu X, Fang F, Chang Y. Sci China Life Sci; 2017 Nov; 60(11):1234-1241. PubMed ID: 28667519 [Abstract] [Full Text] [Related]
3. Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet. Liu X, Gao Y, Li M, Geng C, Xu H, Yang Y, Guo Y, Jiao T, Fang F, Chang Y. J Hepatol; 2015 Sep; 63(3):713-21. PubMed ID: 26026874 [Abstract] [Full Text] [Related]
5. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC. Eur J Pharmacol; 2016 Oct 05; 788():200-209. PubMed ID: 27343380 [Abstract] [Full Text] [Related]
6. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001 [Abstract] [Full Text] [Related]
7. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Yin X, Liu Z, Wang J. Phytomedicine; 2023 Oct 07; 119():155005. PubMed ID: 37562090 [Abstract] [Full Text] [Related]
8. Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1. Cheng B, Gao W, Wu X, Zheng M, Yu Y, Song C, Miao W, Yang Z, He Y, Liu C, Yang W, Yang X, Li Y, Zhang F, Gao Y. J Agric Food Chem; 2020 Apr 08; 68(14):4215-4226. PubMed ID: 32181656 [Abstract] [Full Text] [Related]
9. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice. Thakuri LS, Park CM, Kim HA, Kim HJ, Park JW, Park JC, Rhyu DY. J Ethnopharmacol; 2024 Feb 10; 320():117395. PubMed ID: 37952731 [Abstract] [Full Text] [Related]
10. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway. Wang LF, Wang XN, Huang CC, Hu L, Xiao YF, Guan XH, Qian YS, Deng KY, Xin HB. Lipids Health Dis; 2017 Apr 27; 16(1):82. PubMed ID: 28449683 [Abstract] [Full Text] [Related]
11. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice. Hong Y, Choi SI, Hong E, Kim GH. J Food Sci; 2020 Jul 27; 85(7):2216-2226. PubMed ID: 32579753 [Abstract] [Full Text] [Related]
12. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice. Tian J, Cai M, Jin S, Chen Q, Xu J, Guo Q, Yan Z, Han X, Lu H. Pharm Biol; 2023 Dec 27; 61(1):647-656. PubMed ID: 37038833 [Abstract] [Full Text] [Related]
13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M. J Hepatol; 2014 May 27; 60(5):1017-25. PubMed ID: 24362075 [Abstract] [Full Text] [Related]
14. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet. Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, Huang WC. Cells; 2019 May 11; 8(5):. PubMed ID: 31083505 [Abstract] [Full Text] [Related]
15. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC. Cell Physiol Biochem; 2018 May 11; 49(5):1870-1884. PubMed ID: 30235452 [Abstract] [Full Text] [Related]
16. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. Liou CJ, Dai YW, Wang CL, Fang LW, Huang WC. FASEB J; 2019 Nov 11; 33(11):11791-11803. PubMed ID: 31361524 [Abstract] [Full Text] [Related]
17. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats. Farage AE, Abdo W, Osman A, Abdel-Kareem MA, Hakami ZH, Alsulimani A, Bin-Ammar A, Alanazi AS, Alsuwayt B, Alanazi MM, Antar SA, Kamel EM, Mahmoud AM. Life Sci; 2023 Jun 01; 322():121688. PubMed ID: 37030617 [Abstract] [Full Text] [Related]
18. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway. Shen C, Pan Z, Wu S, Zheng M, Zhong C, Xin X, Lan S, Zhu Z, Liu M, Wu H, Huang Q, Zhang J, Liu Z, Si Y, Tu H, Deng Z, Yu Y, Liu H, Zhong Y, Guo J, Cai J, Xian S. J Ethnopharmacol; 2021 Oct 28; 279():114340. PubMed ID: 34171397 [Abstract] [Full Text] [Related]